With $AMRN being the largest position in my portfolio, of course, I’m taking Vascepa for my cardiovascular health. Why would I buy $AMRN if I don’t believe in the product?
The good news is that after only two months of taking Vascepa (4 grams per day according to recommended dose), my triglyceride level has dropped 46%. The last time my trig was this low was eleven years ago. My total cholesterol has decreased 25% without taking statin. And yes, my LDL level did not go up.
The reason why I want Vascepa so much is because I don’t like to take statin. My doctor has been recommending me to take statin for the last ten years and I keep avoiding it. But I know I’ve to take something. While my total cholesterol is still in need to come down more, I think I will try the natural remedy such as eating more oatmeal and exercise more. Meanwhile, I will keep taking Vascepa to keep my trig low.
I’m hoping that with more time on my Vascepa therapy, my total cholesterol will continue to come down. I’ll let you know after another two months.
Today, I did something that I didn’t think I could do. I literally sold my whole lot of $AMRN just to prove that I could if special situation required it. Without knowing whether the DOW would drop a like rock after the 7% drop on NIKKEI, I sold with the hope of buying back cheap. Unfortunately, price did not go any further down after I sold, so I bought my core and swing trade position back. All at a price higher than I sold for. And Where are the shorts when I need them? Go figure.
My 2 cents.
If you enjoy the content at iBankCoin, please follow us on Twitter
🙁
It could have easily continued to the downside..too.
Stay healthy, Zen.
Hi Sooz,
Yes, I was hoping it would continue to the downside so I could buy more back… oh well, the fact that $AMRN did not tank like most speak volume here.
Cheers!
Wow, those are outstanding and astounding #’s. I am happy for you, It’s also just what I needed to read. You might say just what the dr. ordered.
Do you have any explanations for the broken stock status (outside of the nce situation)?
thanks,
Hi leo,
I don’t think we have a “broken stock status” as you put it. Market has priced $AMRN @ 1 billion market cap currently based on the last update which I think is quite reasonable. In order for the price to go higher, there has to be some concrete proofs such as exponential scripts growth, a good result on combo (statin and Vascepa) that may entice Pfizer to show interest (Lipitor plus Vascepa combo); and the FDA approval of Vascepa for use for people with trig b/w 200-499 levels by December.
In other words, without urgency of a buyout, price action has settled down to a price level commensurate with $AMRN current effort in distributing Vascepa on its own.
Cheers!